Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income - Minority: 2015-2019

Historic Net Income - Minority for Fortress Biotech (FBIO) over the last 1 years, with Mar 2019 value amounting to -$29.9 million.

  • Fortress Biotech's Net Income - Minority was N/A to -$29.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$29.9 million, marking a year-over-year change of. This contributed to the annual value of -$17.9 million for FY2018, which is 73.66% up from last year.
  • Latest data reveals that Fortress Biotech reported Net Income - Minority of -$29.9 million as of Q1 2019, which was down 67.08% from -$17.9 million recorded in Q4 2018.
  • Fortress Biotech's Net Income - Minority's 5-year high stood at -$17.9 million during Q4 2018, with a 5-year trough of -$67.9 million in Q4 2017.
  • For the 3-year period, Fortress Biotech's Net Income - Minority averaged around -$43.0 million, with its median value being -$46.9 million (2018).
  • As far as peak fluctuations go, Fortress Biotech's Net Income - Minority slumped by 62.15% in 2016, and later soared by 73.66% in 2018.
  • Fortress Biotech's Net Income - Minority (Quarterly) stood at -$27.4 million in 2015, then slumped by 62.15% to -$44.5 million in 2016, then plummeted by 52.74% to -$67.9 million in 2017, then spiked by 73.66% to -$17.9 million in 2018, then reached -$29.9 million in 2019.
  • Its last three reported values are -$29.9 million in Q1 2019, -$17.9 million for Q4 2018, and -$46.9 million during Q3 2018.